Effect of atorvastatin on tumor necrosis factor α serum concentration and mRNA expression of adipose in hypercholesterolemic rabbits

Shui-ping Zhao,Zhi-hong Wu,Jie Wu,Shao cai Hong,Ping Deng
DOI: https://doi.org/10.1097/01.fjc.0000167017.69468.61
IF: 3.271
2005-01-01
Journal of Cardiovascular Pharmacology
Abstract:Tumor necrosis factor alpha (TNF alpha) is an inflammatory cytokine involved in atherogenesis. Adipose tissue is an important source of endogenous TNF alpha production. The aim of this study was to evaluate the effect of atorvastatin on TNF alpha serum concentration and mRNA expressions of subcutaneous adipose in hypercholesterolemic rabbits. Sixteen rabbits fed with a high-cholesterol diet for 8 weeks were randomly divided into 2 groups: (1) the high-cholesterol group (n = 8) was maintained on a high-cholesterol diet for 6 weeks; (2) the atorvastatin group (n = 8) had the same high-cholesterol diet plus atorvastatin (2.5 mg/kg/d) for 6 weeks. A control group (n = 5) was fed with a normal diet for 14 weeks. Subcutaneous adipose was collected for mRNA analysis. Additionally, the direct effect of atorvastatin on TNF alpha release and mRNA expression was assayed in primary rabbit adipocytes. TNF alpha levels in serum and adipocyte culture supernatant were measured by ELISA. RT-PCR was used to evaluate TNF alpha mRNA expression in adipose and adipocytes. Serum TNF alpha concentration was significantly associated with serum total cholesterol (TC) and low-density lipoprotein-cholesterol (LDL-C) (both P < 0.01). Compared with the control group, rabbits fed with a high-cholesterol diet showed higher levels of TNF alpha serum concentration and mRNA expression of adipose, both of which were significantly reduced by atorvastatin treatment (both P < 0.05). TNF alpha mRNA expressions of adipose were significantly correlated with circulating TNF alpha levels among the 3 groups (r = 0.51, P < 0.05). Atorvastatin dose-dependently inhibited lipopolysaccharide (LPS)-induced TNF alpha secretion and mRNA expression in cultured adipocytes. In conclusion, atorvastatin can directly inhibit TNF alpha expression and secretion in adipocytes. Atorvastatin reduced TNF alpha serum concentration in hypercholesterolemic rabbits, which might be because of its cholesterol-lowering effect and direct inhibition of TNF alpha expression in adipose.
What problem does this paper attempt to address?